Shares of Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX – Get Free Report) crossed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $0.40 and traded as high as $0.60. Eagle Pharmaceuticals shares last traded at $0.60, with a volume of 300 shares.
Eagle Pharmaceuticals Stock Up 14.3%
The stock’s 50-day moving average is $0.40 and its 200-day moving average is $0.39. The firm has a market cap of $7.79 million, a P/E ratio of 0.51 and a beta of 0.83.
About Eagle Pharmaceuticals
Eagle Pharmaceuticals, Inc is a specialty pharmaceutical company headquartered in Woodcliff Lake, New Jersey, that focuses on the development, manufacturing and commercialization of hospital-administered therapies in the areas of critical care, oncology and rare diseases. Founded in 2007, Eagle has built expertise in complex injectable formulations and orphan drug designation, aiming to address unmet medical needs through both novel products and reformulated generics.
The company’s marketed portfolio in the United States includes Bendeka®, an intravenous formulation of bendamustine for certain types of leukemia and lymphoma; Beleodaq®, approved for relapsed or refractory peripheral T-cell lymphoma; and Empaveli®, a complement inhibitor for the treatment of paroxysmal nocturnal hemoglobinuria.
See Also
- Five stocks we like better than Eagle Pharmaceuticals
- These 3 Insurance Stocks Made New 52-Week Highs: Still Time to Buy?
- 3 Stocks Under $20 to Buy Before a Broader Market Rally
- Petco Faces Tough Competition, But Momentum Is Building
- The Lock-In Effect Is Real—These 3 Homebuilders Are Betting on It
Receive News & Ratings for Eagle Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eagle Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
